Hantelius, Victor http://orcid.org/0009-0005-6109-9678
Ragnarsson, Oskar
Johannsson, Gudmundur
Olsson, Daniel S.
Jakobsson, Sofie
Thurin, Erik
Farahmand, Dan
Skoglund, Thomas
Hallen, Tobias
Funding for this research was provided by:
University of Gothenburg
Article History
Accepted: 5 May 2024
First Online: 20 May 2024
Declarations
:
: DSO has served as a consultant for Ipsen, Phizer, Novo Nordisk, and Sandoz; has received research grants from Sandoz and Pfizer; and is an employee at AstraZeneca as of 30 August 2021. TS has received lecture fees from Abbott. GJ has served as a consultant for Novo Nordisk and AstraZeneca and received lecture fees from Novo Nordisk and Pfizer. None of these activities were related to the work presented in this paper. All other authors have no relevant disclosures.
: The authors declare no competing interests.